The global perfusion bioreactor market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biopharmaceuticals and biotechnology products in emerging economies such as China and India. The large-scale perfusion bioreactors segment is expected to dominate the global market during the forecast period, owing to their high production capacity and low cost per liter.
The small-scale perfusion bioreactors segment accounted for a share of around 40% in 2017, which is expected to decline at a CAGR of -2.8% during the forecast period due to its lower production capacity and higher cost per liter when compared with large-scale perfusion bioreactors. Biopharmaceutical companies are estimated to account for around 60% share in 2017, followed by biotech companies with a share of around 30%.
Some Of The Growth Factors Of This Market:
- The increasing number of patients with chronic diseases such as diabetes and cancer is expected to drive the growth of the perfusion bioreactor market.
- The increasing demand for organ transplants is also expected to fuel the growth of the perfusion bioreactor market.
- The rising prevalence of infectious diseases such as HIV/AIDS, malaria, and tuberculosis is also expected to drive the growth of this market in developing countries where these diseases are prevalent.
- Increasing research and development activities in this field are also anticipated to fuel the growth of this market over the forecast period (2017-2026).
- Technological advancements in perfusion bioreactors are anticipated to provide new opportunities for players operating in this market.
Industry Growth Insights published a new data on “Perfusion Bioreactor Market”. The research report is titled “Perfusion Bioreactor Market research by Types (Small Scale(50 Liters to 1,000 Liters), Large Scale(>1,000 Liters)), By Applications (Biopharmaceutical Companies, Biotechnology Companies, Others), By Players/Companies FiberCell Systems Inc, Zellwerk GmbH, Cell Culture Company, ATMI Incorporated, PBS Biotech, Inc., GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Perfusion Bioreactor Market Research Report
By Type
Small Scale(50 Liters to 1,000 Liters), Large Scale(>1,000 Liters)
By Application
Biopharmaceutical Companies, Biotechnology Companies, Others
By Companies
FiberCell Systems Inc, Zellwerk GmbH, Cell Culture Company, ATMI Incorporated, PBS Biotech, Inc., GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Perfusion Bioreactor Market Report Segments:
The global Perfusion Bioreactor market is segmented on the basis of:
Types
Small Scale(50 Liters to 1,000 Liters), Large Scale(>1,000 Liters)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- FiberCell Systems Inc
- Zellwerk GmbH
- Cell Culture Company
- ATMI Incorporated
- PBS Biotech, Inc.
- GE Healthcare Life Sciences
- Applikon Biotechnology
- WAVE Life Sciences
Highlights of The Perfusion Bioreactor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Scale(50 Liters to 1,000 Liters)
- Large Scale(>1,000 Liters)
- By Application:
- Biopharmaceutical Companies
- Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Perfusion Bioreactor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A perfusion bioreactor is a device that helps to increase the flow of blood and other fluids through the body. This can be helpful in treating conditions such as heart failure, stroke, and kidney disease.
Some of the key players operating in the perfusion bioreactor market are FiberCell Systems Inc, Zellwerk GmbH, Cell Culture Company, ATMI Incorporated, PBS Biotech, Inc., GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences.
The perfusion bioreactor market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Perfusion Bioreactor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Perfusion Bioreactor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Perfusion Bioreactor Market - Supply Chain
4.5. Global Perfusion Bioreactor Market Forecast
4.5.1. Perfusion Bioreactor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Perfusion Bioreactor Market Size (000 Units) and Y-o-Y Growth
4.5.3. Perfusion Bioreactor Market Absolute $ Opportunity
5. Global Perfusion Bioreactor Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Perfusion Bioreactor Market Size and Volume Forecast by Type
5.3.1. Small Scale(50 Liters to 1,000 Liters)
5.3.2. Large Scale(>1,000 Liters)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Perfusion Bioreactor Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Perfusion Bioreactor Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Biotechnology Companies
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Perfusion Bioreactor Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Perfusion Bioreactor Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Perfusion Bioreactor Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Perfusion Bioreactor Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Perfusion Bioreactor Demand Share Forecast, 2019-2029
9. North America Perfusion Bioreactor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Perfusion Bioreactor Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Perfusion Bioreactor Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Biotechnology Companies
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Perfusion Bioreactor Market Size and Volume Forecast by Type
9.7.1. Small Scale(50 Liters to 1,000 Liters)
9.7.2. Large Scale(>1,000 Liters)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Perfusion Bioreactor Demand Share Forecast, 2019-2029
10. Latin America Perfusion Bioreactor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Perfusion Bioreactor Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Perfusion Bioreactor Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Biotechnology Companies
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Perfusion Bioreactor Market Size and Volume Forecast by Type
10.7.1. Small Scale(50 Liters to 1,000 Liters)
10.7.2. Large Scale(>1,000 Liters)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Perfusion Bioreactor Demand Share Forecast, 2019-2029
11. Europe Perfusion Bioreactor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Perfusion Bioreactor Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Perfusion Bioreactor Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Biotechnology Companies
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Perfusion Bioreactor Market Size and Volume Forecast by Type
11.7.1. Small Scale(50 Liters to 1,000 Liters)
11.7.2. Large Scale(>1,000 Liters)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth rojections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Perfusion Bioreactor Demand Share, 2019-2029
12. Asia Pacific Perfusion Bioreactor Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Perfusion Bioreactor Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Perfusion Bioreactor Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Biotechnology Companies
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Perfusion Bioreactor Market Size and Volume Forecast by Type
12.7.1. Small Scale(50 Liters to 1,000 Liters)
12.7.2. Large Scale(>1,000 Liters)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Perfusion Bioreactor Demand Share, 2019-2029
13. Middle East & Africa Perfusion Bioreactor Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Perfusion Bioreactor Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Perfusion Bioreactor Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Biotechnology Companies
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Perfusion Bioreactor Market Size and Volume Forecast by Type
13.7.1. Small Scale(50 Liters to 1,000 Liters)
13.7.2. Large Scale(>1,000 Liters)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Perfusion Bioreactor Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Perfusion Bioreactor Market: Market Share Analysis
14.2. Perfusion Bioreactor Distributors and Customers
14.3. Perfusion Bioreactor Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. FiberCell Systems Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zellwerk GmbH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cell Culture Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ATMI Incorporated
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PBS Biotech, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GE Healthcare Life Sciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Applikon Biotechnology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. WAVE Life Sciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
